Experienced Investors

Massachusetts is home to a vibrant community of angel investors, venture capitalists and private equity investors. These investors are willing to fund life sciences innovation and possess deep experience in how to do so.

Massachusetts biotechnology companies received a record $1.071 billion in Venture Capital financing in 2011, representing 23 percent of all U.S. venture capital for biotech in that year.

Connect With Us

Facebook LinkedIn Twitter